Skip to main content

Table 1 Demographics and clinicopathological characteristics of lung carcinoid tumors

From: Prognostic nomogram for predicting long-term cancer-specific survival in patients with lung carcinoid tumors

 

All (N = 1956)

Age at diagnosis, years

  < 60

952 (48.7%)

  ≥ 60

1004 ((51.3%)

Gender

 Female

1302 (66.6%)

 Male

654 (33.4%)

Race

 White

1745 (89.2%)

 Other

211 (10.8%)

Insurance

 Yes

1587 (81.1%)

 No

369 (18.9%)

Marital status

 Married

1140 (58.3%)

 Unmarried

816 (41.7%)

Primary site

 Main bronchus

108 (5.5%)

 Upper lobe, lung

621 (31.7%)

 Middle lobe, lung

337 (17.2%)

 Lower lobe, lung

792 (40.5%)

 Overlapping lesion of lung

37 (1.9%)

 Lung, NOS

61 (3.2%)

Grade

 Well

1451 (74.2%)

 Moderately/Poorly/Undifferentiated

505 (25.8%)

Laterality

 Right

1142 (58.4%)

 Other

814 (46.4%)

Historic Stage

 Localized

1389 (71.0%)

 Regional/Distant/Unstaged

567 (29.0%)

Histological type

 Typical carcinoid

1702 (87.0%)

 Atypical carcinoid

254 (13.0%)

T stage

 T1

1133 (57.9%)

 T2-T4

823 (42.1%)

N stage

 N0

1622 (83.0%)

 N1-N3

334 (17.0%)

M stage

 M0

1814 (92.7%)

 M1

142 (7.3%)

Surgery

 No

225 (11.5%)

 Lobectomy

1235 (63.1%)

 Local

119 (6.1%)

 Wedge

264 (13.5%)

 Pneumonectomy

103 (5.3%)

 NOS

10 (0.5%)

Radiation

 No

1847 (94.4%)

 Yes

109 (5.6%)

Chemotherapy

 No

1843 (94.2%)

 Yes

113 (5.8%)

Radiation after surgery

 No

1898 (97.0%)

 Yes

58 (3.0%)

Tumor size

  < 20 mm

841 (43.0%)

 20–40 mm

873 (44.6%)

  > 40 mm

242 (12.4%)